ORCL — OracleFREE
Price
$184.29
previous close
Median target
$280
across current calls
Implied return
+51.9%
median target vs. price
Coverage
26 analysts · 33 calls
current predictions
Consensus
26/7/0+26 net
Buy / Hold / Sell
Current analyst calls on ORCL
Sorted by implied return. Each row is one analyst's live rating and price target.
| Analyst | Score | Rank | Succ% | Ret% | Firm | Call | Target | Impl. return | Updated |
|---|---|---|---|---|---|---|---|---|---|
| Alex Zukin | – | – | – | Wolfe Research | Buy | $400 | +117.1% | Oct 17, 2025 | |
| Alex Zukin | – | – | – | Wolfe Research | Buy | $400 | +117.1% | Sep 10, 2025 | |
| John Difucci | – | – | – | Guggenheim | Buy | $400 | +117.1% | Mar 12, 2026 | |
| Brent Bracelin | – | – | – | Piper Sandler | Buy | $380 | +106.2% | Oct 17, 2025 | |
| Stefan Slowinski | – | – | – | Exane BNP Paribas | Buy | $377 | +104.6% | Sep 10, 2025 | |
| Cherilyn Radbourne | – | – | – | TD Cowen | Buy | $375 | +103.5% | Sep 16, 2025 | |
| Ben Reitzes | – | – | – | Melius Research | Buy | $370 | +100.8% | Sep 10, 2025 | |
| Mark Moerdler | – | – | – | Bernstein | Buy | $339 | +84.0% | Dec 11, 2025 | |
| Brent Thill | – | – | – | Jefferies | Buy | $320 | +73.6% | Mar 6, 2026 | |
| Siti Panigrahi | – | – | – | Mizuho | Buy | $320 | +73.6% | Mar 16, 2026 | |
| Mark Moerdler | – | – | – | Bernstein | Buy | $319 | +73.1% | Mar 30, 2026 | |
| Mark Moerdler | – | – | – | Bernstein | Buy | $308 | +67.1% | Aug 6, 2025 | |
| Nay Soe Naing | – | – | – | Berenberg Bank | Hold | $306 | +66.0% | Oct 20, 2025 | |
| Nay Soe Naing | – | – | – | Berenberg Bank | Hold | $306 | +66.0% | Sep 15, 2025 | |
| Brad Zelnick | – | – | – | Deutsche Bank | Buy | $300 | +62.8% | Mar 9, 2026 | |
| Brent Bracelin | – | – | – | Piper Sandler | Buy | $290 | +57.4% | Dec 11, 2025 | |
| Michael Turrin | – | – | – | Wells Fargo | Buy | $280 | +51.9% | May 20, 2026 | |
| Daniel Ives | – | – | – | Wedbush | Buy | $275 | +49.2% | May 13, 2026 | |
| Brett Huff | – | – | – | Stephens | Hold | $254 | +37.8% | Apr 7, 2026 | |
| Brett Huff | – | – | – | Stephens | Hold | $254 | +37.8% | Dec 11, 2025 | |
| Derrick Wood | – | – | – | TD Cowen | Buy | $250 | +35.7% | Mar 11, 2026 | |
| Karl Keirstead | – | – | – | UBS | Buy | $250 | +35.7% | Apr 7, 2026 | |
| Hannah Rudoff | – | – | – | Piper Sandler | Buy | $240 | +30.2% | Feb 3, 2026 | |
| Kash Rangan | – | – | – | Goldman Sachs | Buy | $240 | +30.2% | Jan 11, 2026 | |
| Brian Schwartz | – | – | – | Oppenheimer | Buy | $235 | +27.5% | May 12, 2026 | |
| Thomas Blakey | – | – | – | Cantor Fitzgerald | Buy | $229 | +24.3% | Mar 11, 2026 | |
| Brad Reback | – | – | – | Stifel | Buy | $220 | +19.4% | Mar 11, 2026 | |
| Kirk Materne | – | – | – | Evercore ISI Group | Buy | $220 | +19.4% | Mar 5, 2026 | |
| Mark Murphy | – | – | – | J.P. Morgan | Buy | $210 | +14.0% | Mar 11, 2026 | |
| Keith Weiss | – | – | – | Morgan Stanley | Hold | $207 | +12.3% | Apr 23, 2026 | |
| Robert Oliver | – | – | – | Baird | Buy | $200 | +8.5% | Mar 10, 2026 | |
| Ben Reitzes | – | – | – | Melius Research | Hold | $160 | -13.2% | Feb 9, 2026 | |
| Steven Koenig | – | – | – | Macquarie | Hold | $56 | -69.6% | Dec 13, 2019 |
Analyst track records are Premium — unlock every analyst's score, rank and success rate.
Implied return = price target ÷ yesterday's close − 1: the move the stock would make if the analyst's target were hit. These are forward-looking predictions, not realized returns. Only reliable-basis calls are included; the consensus figures above are computed from the calls in this table.